On November 3, 2023, Mustang Bio, Inc. closed the transaction. The transaction included participation from a single investor. In connection with the offering, the placement agent received is $308,000.08 and warrants to purchase up to 155,294 shares of common stock exercisable at $2.125 per share.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4208 USD | -4.86% |
|
-13.50% | -68.83% |
Jun. 21 | Sector Update: Health Care Stocks Steady Premarket Friday | MT |
Jun. 20 | Mustang Bio to Raise $2.5 Million From Share Offering | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-68.83% | 15.43M | |
+20.95% | 127B | |
+23.00% | 116B | |
+25.15% | 27.69B | |
-19.75% | 19.62B | |
-16.57% | 16.26B | |
-16.56% | 15.49B | |
+11.19% | 14.81B | |
-46.65% | 14.39B | |
+57.74% | 14.11B |
- Stock Market
- Equities
- MBIO Stock
- News Mustang Bio, Inc.
- Mustang Bio, Inc. announced that it has received $4.742942 million in funding